Ciliatech are delighted to announce the appointment of Stephanie C. Jones to the position of Global Vice President, Clinical and Medical A:airs where she will sit on our senior leadership team.
Stephanie joins us from Ora Inc (Andover, Massachusetts), a market-leading full service CRO specializing in ophthalmology – most recently holding the position of Manager, Clinical Operations and Project Management in R&D, medical aIairs and strategic development, where Stephanie oversaw a portfolio of projects developing new technologies and clinical trial endpoints, and supporting investment partnership asset growth and clinical development.
Prior to this and spanning 17 years in a career completely dedicated to Ophthalmology, Stephanie’s early career started at St Thomas’ Hospital in London, one of the largest teaching hospitals in the UK, researching aqueous humour dynamics. Alongside academia, Stephanie developed the KCL Frost Research Unit to become a premier UK site for international industry collaborations, bringing in significant six-figure funding and participation in almost all global landmark glaucoma clinical trials of emerging drugs devices of the last two decades. Stephanie worked on over fifty ophthalmology trials over her ten years at St Thomas’ Hospital and managed a team of greater than thirty clinical staI. Stephanie also did freelance work in cataract audit, medical writing, medico-legal and clinical trial consulting during her time in the public sector.
Stephanie moved from the provider side into industry starting her career with Glaukos Corporation (Aliso Viejo, California) as CRA where first hand she was instrumental in broadening OUS clinical activity, performing site selection, contracting, quality & regulatory and budget planning across EMEA, USA and APAC including clinical project management. Following this role Stephanie was promoted to Global Medical Marketing Specialist where she was involved in statistical analyses, manuscript writing, abstract development and post-market approval studies. Stephanie then took up the position of Head of Eye Science for Rayner Intraocular Lenses Ltd (Worthing, UK) where she managed a global team covering clinical & medical aIairs and education, with extensive additional consultation involvement to R&D and regulatory teams advising on EU-MDR transition requirements. Stephanie was responsible for clinical strategy and launch activity for an innovative first-in-class class IOL, and IDE submissions.
Stephanie has an equally impressive academic background – first gaining her undergraduate degree from UCL in London in 2007, and later gaining a Master of Science Degree in Clinical Trials from the highly prestigious London School of Hygiene and Tropical Medicine. Stephanie continues her academic development currently studying for a Postgraduate Certificate in Medical Law, Ethics and Intellectual Property of Medicine. Stephanie is committed to consistently publishing throughout her navigations between the industry and academic worlds, with contributions and authorship to numerous scientific journals and book chapters for dry eye, allergy and glaucoma.
Stephanie resides in New York City and started her position with Ciliatech on Monday 2nd September 2024.
